Skip to content

EQRx, Inc.

Delisted

CIK 1843762fmd_1Z37WPG2ZFD1HQVYRRYD7YHQXPManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2023, 12 periods

Latest annual · FY2022

Millions
Operating income
(356)
Net income
(169)
Free cash flow
(288)

Latest quarter · Q3 FY2023

Millions
Operating income
(102)
Net income
(83)
Free cash flow
(62)
Open Financials

EQRx, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Operating income-$355.9 million-$196.4 million10-K 2023-02-23 · proof
Net income-$169.1 million-$100 million10-K 2023-02-23 · proof
Cash from operating activities-$287.3 million-$183.2 million10-K 2023-02-23 · proof
Free cash flow-$288.4 million-$183.6 million10-K 2023-02-23 · proof
Total assets$1.5 billion$1.7 billion-15.9%10-K 2023-02-23 · proof
Total liabilities$66.2 million$214.6 million-69.2%10-K 2023-02-23 · proof
Cash and cash equivalents$494.1 million$1.7 billion-70.6%10-K 2023-02-23 · proof
What was EQRx, Inc.'s operating income in fiscal 2022?
EQRx, Inc. reported operating income of -$355.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$196.4 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What was EQRx, Inc.'s net income in fiscal 2022?
EQRx, Inc. reported net income of -$169.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$100 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What was EQRx, Inc.'s cash from operating activities in fiscal 2022?
EQRx, Inc. reported cash from operating activities of -$287.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$183.2 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What was EQRx, Inc.'s free cash flow in fiscal 2022?
EQRx, Inc. reported free cash flow of -$288.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$183.6 million the year before. Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What are EQRx, Inc.'s total assets?
As of Dec 31, 2022, EQRx, Inc. reported total assets of $1.5 billion, against $1.7 billion a year earlier (-15.9%). Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What are EQRx, Inc.'s total liabilities?
As of Dec 31, 2022, EQRx, Inc. reported total liabilities of $66.2 million, against $214.6 million a year earlier (-69.2%). Source: the 10-K filed with the SEC on Feb 23, 2023. SEC
What are EQRx, Inc.'s cash and cash equivalents?
As of Dec 31, 2022, EQRx, Inc. reported cash and cash equivalents of $494.1 million, against $1.7 billion a year earlier (-70.6%). Source: the 10-K filed with the SEC on Feb 23, 2023. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1843762&period_type=annual&limit=5"

Information only, not investment advice.